Supported by an alliance of international patient organizations and health advocacy groups, CSL Vifor takes a leading role annually to educate people about the importance of iron for the body and what can happen if iron levels are not properly managed. It encourages people to become better informed and to seek medical advice from their physicians.
'Iron Deficiency Day stands as a mainstay of our ongoing commitment to underscore the significance of taking iron seriously', said Herve Gisserot, General Manager CSL Vifor. 'Despite the serious consequences and high prevalence of iron deficiency, the condition remains under-recognized. At CSL, we are driven by our promise to patients around the world and together with our partners, we are committed to further building awareness, helping patients recognize their symptoms, and improving access to care.'
Although iron deficiency affects one in three people worldwide2, it is most prevalent in premenopausal women, pregnant women, and children under five3. However, early access to diagnosis and treatment remains a challenge. Disparities in gender4, educational status4,5 and geography5 are just some of the many aspects that may further limit access to information, diagnosis, and medical support. To address this unmet need, CSL Vifor raises awareness of iron deficiency and iron deficiency anemia across
'Iron deficiency affects about half of the patients suffering from chronic kidney disease. However, geographic and socio-demographic barriers often prevent many patients from receiving a timely diagnosis', commented
Iron Deficiency Day is endorsed by multiple international organizations including the Heart Failure Policy Network,
CSL Vifor encourages the global community to join and raise awareness on iron deficiency by promoting education and early intervention.
About CSL Vifor
CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. We specialize in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision healthcare, aiming to help patients around the world lead better, healthier lives. Headquartered in
The parent company, CSL (ASX: CSL; USOTC: CSLLY), headquartered in
Notes to Editors
Takeironseriously.com is intended to provide educational information to an international audience outside the US; it is available in 17 languages. All information on the site is intended for educational purposes only and should not be used to replace a discussion with a healthcare professional. All decisions regarding patient care must be handled by a healthcare professional and be made based on the unique needs of each patient.
About iron deficiency
Iron plays a vital role in many bodily processes, including the production of red blood cells, effective heart and brain function, and the prevention of infection and illness. Without enough iron, the body is unable to function properly. Common symptoms include fatigue, dizziness, and shortness of breath. Iron deficiency and iron deficiency anemia is estimated to affect one in three people worldwide6, yet despite the serious consequences and high prevalence7, it remains an under-recognized condition.
The effects of iron deficiency differ from person to person but can be linked to an overall decline in general health and well-being8. Even without anemia, iron deficiency can be debilitating, exacerbate an underlying chronic disease and lead to increased morbidity and mortality8. Common symptoms include fatigue8,9,10 pale skin9, brittle nails9, 11, craving non-food items such as dirt, clay and ice12, and an inability to concentrate8, 13. In children, iron deficiency can significantly impair cognitive and motor development14.
Left untreated, iron deficiency can develop into iron deficiency anemia. Multiple organizations, including the
Contact:
Tel: +41 79 957 96 73
Email: media@viforpharma.com
(C) 2023 Electronic News Publishing, source